Male breast carcinoma: An evaluation of prognostic factors contributing to a poorer outcome
暂无分享,去创建一个
M. Loda | K. Hughes | G. Heatley | Arthur K. C. Lee | M. Camus | M. Joshi | C. Pedersen
[1] Elisa T. Lee,et al. Statistical Methods for Survival Data Analysis , 1994, IEEE Transactions on Reliability.
[2] K. Hughes,et al. Ductal carcinoma in situ of the male breast , 1994, Cancer.
[3] D. Berry,et al. c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. , 1994, The New England journal of medicine.
[4] M. Bm,et al. Lobular carcinoma of the male breast , 1994 .
[5] A. Thor,et al. Prognostic significance of p53 overexpression in node-negative breast carcinoma: preliminary studies support cautious optimism. , 1993 .
[6] A. Levine,et al. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[7] E. Kawasaki,et al. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. , 1992, Journal of the National Cancer Institute.
[8] P. Borgen,et al. Current Management of Male Breast Cancer , 1992 .
[9] S. Fox,et al. Lack of c-erbB-2 oncoprotein expression in male breast carcinoma. , 1991, Journal of clinical pathology.
[10] B. Vogelstein,et al. p53 mutations in human cancers. , 1991, Science.
[11] J. Soares,et al. Morphology of male breast carcinoma in the evaluation of prognosis. , 1990, Pathology, research and practice.
[12] R. W. Crichlow,et al. Male breast cancer. , 1990, The Surgical clinics of North America.
[13] A. Lee,et al. Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Y. Monden,et al. Cancer of the male breast , 1990, Journal of surgical oncology.
[15] A. Schwartz,et al. Infiltrating cribriform carcinoma of the breast: a distinctive clinicopathologic entity. , 1990, Human pathology.
[16] C. Carter,et al. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases , 1989, Cancer.
[17] F. Rilke,et al. P53 expression in breast cancer , 1988, International journal of cancer.
[18] S. Martin,et al. Angioinvasion in breast carcinoma. An immunohistochemical study of factor VIII‐related antigen , 1987, Cancer.
[19] A. Hart,et al. A retrospective study of male breast cancer in Holland , 1985, The British journal of surgery.
[20] J. Hainsworth,et al. Inflammatory carcinoma of the breast. Clinical review and summary of the Vanderbilt experience with multi-modality therapy. , 1985, The American journal of medicine.
[21] C. Elston,et al. THE ASSESSMENT OF HISTOLOGICAL DIFFERENTIATION IN BREAST CANCER , 1984 .
[22] D. Page,et al. Invasive cribriform carcinoma of the breast † , 1983, Histopathology.
[23] N. Khanna,et al. Paget's disease of the male breast: A clinicopathologic study and a collective review , 1983, Journal of surgical oncology.
[24] S. Moschella,et al. Paget's disease of the male breast. , 1982, Journal of the American Academy of Dermatology.
[25] J. Gustafsson,et al. Estrogen receptor concentrations in 269 cases of histologically classified human breast cancer , 1980, Cancer.
[26] D. Schottenfeld,et al. Male Breast Cancer: A Clinicopathologic Study of 97 Cases , 1978, Annals of surgery.
[27] C. Perez-Mesa,et al. Inflammatory carcinoma of the breast , 1978, Cancer.
[28] W. H. Mathews,et al. Paget disease of the male breast. , 1977, Archives of surgery.
[29] James H. Ware,et al. On distribution-free tests for equality of survival distributions , 1977 .
[30] R. W. Slack. The survival rate of men with carcinoma of the breast , 1975, The British journal of surgery.
[31] B. Fisher,et al. The pathology of invasive breast cancer A Syllabus Derived from Findings of the National Surgical Adjuvant Breast Project (Protocol No. 4) , 1975, Cancer.
[32] O. Scheike. Male Breast Cancer , 1974, British Journal of Cancer.
[33] S. Teitelbaum,et al. Inflammatory carcinoma of the breast. A Pathologic Definition , 1974, Cancer.
[34] J. Visfeldt,et al. Male breast cancer. I. Histologic typing and grading of 187 Danish cases , 1973, Cancer.
[35] B. Czernobilsky,et al. Paget's disease of the male breast , 1969, Cancer.
[36] H. Taylor,et al. Carcinoma of the male breast , 1969, Cancer.
[37] J. Gleysteen,et al. Cancer of the male breast. Forty cases , 1967, Cancer.
[38] P. Aichroth,et al. Cancer of the Male Breast , 1965, British Journal of Cancer.
[39] R. Turner-Warwick. The lymphatics of the breast , 1959, The British journal of surgery.
[40] H. Bloom,et al. Histological Grading and Prognosis in Breast Cancer , 1957, British Journal of Cancer.
[41] N. Treves. Inflammatory carcinoma of the breast in the male patient. , 1953, Surgery.
[42] S. Andreola,et al. Prognosis of breast cancer in males: an analysis of 170 cases. , 1994, European journal of cancer.
[43] S. Dische,et al. The prognosis of breast cancer in males a report of 335 cases , 1993, Cancer.
[44] M. Loda,et al. DNA ploidy, proliferation, and neu-oncogene protein overexpression in breast carcinoma. , 1992, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[45] C R King,et al. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[46] W. McGuire,et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.
[47] R. Hultborn,et al. Male breast carcinoma. I. A study of the total material reported to the Swedish Cancer Registry 1958-1967 with respect to clinical and histopathologic parameters. , 1987, Acta oncologica.
[48] G. Kerr,et al. Carcinoma of the male breast: report of a series of 88 cases. , 1976, Clinical radiology.